Tag Archives: Dr Suzanne Vernon
Genome-epigenome interactions associated with ME/CFS
Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, by Santiago Herrera, Wilfred C de Vega, David Ashbrook, Suzanne D Vernon and Patrick O McGowan in Epigenetics 2018 [Published online: 5 Dec 2018] Research abstract: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) … Continue reading
C-Reactive protein response in patients with Post-Treatment Lyme Disease symptoms versus those with ME/CFS
Research letter: C-Reactive Protein Response in Patients With Post-Treatment Lyme Disease Symptoms Versus Those With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, by Melanie Uhde, Alyssa Indart, Brian A Fallon, Gary P Wormser, Adriana R Marques, Suzanne D Vernon, and Armin Alaedini in Clinical Infectious diseases, 2018;XX(00):2–2 To the Editor—There is substantial overlap in symptoms, … Continue reading
Integration of DNA methylation & health scores identifies subtypes in ME/CFS
Research abstract: Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome, by Wilfred C de Vega, Lauren Erdman, Suzanne D Vernon, Anna Goldenberg & Patrick O McGowan in Epigenomics. 2018 Apr 25. doi: 10.2217/epi-2017-0150. [Epub … Continue reading
Markers of non-coeliac wheat sensitivity in patients with ME/CFS
Research letter: Markers of non-coeliac wheat sensitivity in patients with myalgic encephalomyelitis/ chronic fatigue syndrome, by Melanie Uhde, Alyssa C Indart, Xuechen B Yu, Sophie S Jang, Roberto De Giorgio, Peter H R Green, Umberto Volta, Suzanne D Vernon, Armin Alaedini … Continue reading
Cortene – a new drug trial & disease hypothesis for ME/CFS
Cortene In his blog, Health Rising, Cort Johnson introduces a new drug trial and hypothesis for ME/CFS. With the help of Dr Lucinda Bateman and Dr Suzanne Vernon a small drug company, Cortene, will be conducting a small proof-of-concept trial of a new … Continue reading
Genome-epigenome interactions associated with ME/CFS
Research abstract: Genome-Epigenome Interactions Associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, by Santiago Herrera, Wilfred C de Vega, David Ashbrook, Suzanne D Vernon, Patrick O McGowan in Biorxiv [preprint 22 Dec 2017] Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is an example of … Continue reading
Epigenetic modifications & glucocorticoid sensitivity in ME/CFS
Research abstract: Background: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating idiopathic disease characterized by unexplained fatigue that fails to resolve with sufficient rest. Diagnosis is based on a list of symptoms and exclusion of other fatigue-related health conditions. Despite … Continue reading
Neural consequences of PEM in ME/CFS
Research abstract: Highlights: Acute exercise affects symptoms, cognitive performance and brain function in ME/CFS. Symptom provocation by exercise is a useful model to study post-exertion malaise. Objective neurophysiological evidence of the phenomenon of post-exertion malaise. Post exertion malaise is one … Continue reading
A better way to measure ME/CFS experience is needed
Research abstract: PURPOSE: Debilitating fatigue is a core symptom of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); however, the utility of patient-reported symptom outcome measures of fatigue for ME/CFS patients is problematic due to ceiling effects and issues with reliability and validity. … Continue reading
Bateman Horne Centre outlines steps to mainstream ME/CFS research
Health rising blog post, by Cort Johnson, 30 June 2016: Bateman-Horne Center Tells NIH to Create Building Blocks For Success For Chronic Fatigue Syndrome “The Bateman Horne Center – a clinic specializing in ME/CFS, with a large number of patients … Continue reading
